Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5925
    -0.0009 (-0.15%)
     
  • NZD/EUR

    0.5542
    +0.0001 (+0.03%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.96
    -0.40 (-0.48%)
     
  • GOLD

    2,345.30
    +3.20 (+0.14%)
     
  • NASDAQ

    17,531.90
    +60.43 (+0.35%)
     
  • FTSE

    8,039.47
    -5.34 (-0.07%)
     
  • Dow Jones

    38,369.44
    -134.25 (-0.35%)
     
  • DAX

    18,064.06
    -73.59 (-0.41%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • NZD/JPY

    91.8030
    +0.0370 (+0.04%)
     

Company News For Jun 12, 2018

Crown Castle (CCI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
  • Envision Healthcare Corp.’s EVHC shares increased 2.3% after private-equity firm KKR & Co. has reached a deal to buy the company for about $5.5 billion in cash

  • Boston Scientific Corp. BSX surged 7.4% following a report by the Wall Street Journal that rival Stryker Corp SYK has offered a bid to buy the company

  • Sempra Energy’s SRE shares jumped 15.5% following the news that activist investors Elliot Management and Bluescape Resources have suggested a “value creation” strategy for the company

  • Shares of Adient plc ADNT plunged 15.6% after projecting yearly adjusted EBITDA of around $1.25 billion for fiscal 2018, lower than previous estimate of $1.40 billion to $1.45 billion 


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Sempra Energy (SRE) : Free Stock Analysis Report
 
Adient PLC (ADNT) : Free Stock Analysis Report
 
Boston Scientific Corporation (BSX) : Free Stock Analysis Report
 
Stryker Corporation (SYK) : Free Stock Analysis Report
 
Envision Healthcare Corporation (EVHC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research